Hierarchical Bayes Approach to Estimate the Treatment Effect for Randomized Controlled Trials

被引:2
|
作者
Liang, Xinya [1 ]
Kamata, Akihito [2 ]
Li, Ji [1 ]
机构
[1] Univ Arkansas, Fayetteville, AR 72701 USA
[2] Southern Methodist Univ, Dallas, TX 75275 USA
关键词
hierarchical Bayes model; hyper prior; empirical Bayes model; randomized controlled trial; treatment effect; INFORMATIVE PRIORS; MODELS; PARAMETERS; SIZE; DISTRIBUTIONS; INFERENCE; VARIANCE;
D O I
10.1177/0013164420909885
中图分类号
G44 [教育心理学];
学科分类号
0402 ; 040202 ;
摘要
One important issue in Bayesian estimation is the determination of an effective informative prior. In hierarchical Bayes models, the uncertainty of hyperparameters in a prior can be further modeled via their own priors, namely, hyper priors. This study introduces a framework to construct hyper priors for both the mean and the variance hyperparameters for estimating the treatment effect in a two-group randomized controlled trial. Assuming a random sample of treatment effect sizes is obtained from past studies, the hyper priors can be constructed based on the sampling distributions of the effect size mean and precision. The performance of the hierarchical Bayes approach was compared with the empirical Bayes approach (hyperparameters are fixed values or point estimates) and the ordinary least squares (OLS) method via simulation. The design factors for data generation included the sample treatment effect size, treatment/control group size ratio, and sample size. Each generated data set was analyzed using the hierarchical Bayes approach with three hyper priors, the empirical Bayes approach with twelve priors (including correct and inaccurate priors), and the OLS method. Results indicated that the proposed hierarchical Bayes approach generally outperformed the empirical Bayes approach and the OLS method, especially with small samples. When more sample effect sizes were available, the treatment effect was estimated more accurately regardless of the sample sizes. Practical implications and future research directions are discussed.
引用
收藏
页码:1090 / 1114
页数:25
相关论文
共 50 条
  • [21] Frequent fragility of randomized controlled trials for HCC treatment
    Hao Zhang
    Jingtao Li
    Wenting Zeng
    BMC Cancer, 21
  • [22] Effect of pravastatin treatment on circulating adiponectin: a meta-analysis of randomized controlled trials
    Shu, Xiangrong
    Chi, Liqun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 1633 - 1641
  • [23] Effect of atorvastatin treatment on circulating adiponectin: a meta-analysis of randomized controlled trials
    Xiaoyu Liu
    Wei Zhang
    Ming Zhao
    Guowei Jia
    Rongguo Sun
    Lipids in Health and Disease, 18
  • [24] Quality of randomized controlled trials reporting in the treatment of sarcomas
    Toulmonde, M.
    Bellera, C.
    Mathoulin-Pelissier, S.
    Bin Bui, N.
    Italiano, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Conducting Randomized Controlled Trials for the Treatment of Enteric Fever
    Shrestha, Poojan
    Arjyal, Amit
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (10) : 1503 - +
  • [26] Surgical treatment of pancreatic cancer - randomized controlled trials
    Andren-Sandberg, Ake
    Hedberg, Mats
    Juralowicz, Piotr
    Talar-Wojnarowska, Renata
    Malecka-Panas, Ewa
    PRZEGLAD GASTROENTEROLOGICZNY, 2011, 6 (03): : 133 - 138
  • [27] Quality of Randomized Controlled Trials Reporting in the Treatment of Sarcomas
    Toulmonde, Maud
    Bellera, Carine
    Mathoulin-Pelissier, Simone
    Debled, Marc
    Bui, Binh
    Italiano, Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (09) : 1204 - 1209
  • [28] Frequent fragility of randomized controlled trials for HCC treatment
    Zhang, Hao
    Li, Jingtao
    Zeng, Wenting
    BMC CANCER, 2021, 21 (01)
  • [29] The Treatment of Scabies A Systematic Review of Randomized Controlled Trials
    Dressler, Corinna
    Rosumeck, Stefanie
    Sunderkotter, Cord
    Werner, Ricardo Niklas
    Nast, Alexander
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2016, 113 (45): : 757 - +
  • [30] Treatment of essential hypertension: Ongoing randomized controlled trials
    Chalon, S
    Brudi, P
    Lechat, P
    THERAPIE, 1996, 51 (06): : 631 - 638